ABTI Alpha-Beta Technology Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABTI Alpha-Beta Technology

ABTI 0.000200

0.0%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: biowa who wrote (186)	6/30/1997 12:46:00 PM
From: Rosemary	of 572

Biowa, You are going to make me quote directly from the mail-out so you can make your own decisions on what they said: "The Company has scheduled July 24 & 25, as meeting dates for an indepentent panel, to perform a final review of the blinded infection data from the Company's Phase III clinical trial. Following the panel review, the database will be unblinded and the statistical analysis will be completed. The results of the trial are scheduled to be announced within two weeks of the panel meeting." Thus the date of Aug, 9th. which is an assumption on my part, that is the end of the two week period from the panel's meeting.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next